William D. Humphries, Director at Clearside Biomedical, Inc. (CLSD), bought 5,586 shares at $1.78 ($10K) on 2020-08-18, disclosed to the SEC on 2020-08-18.
Open-market purchase of $10k CLSD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| BHC | SELL | 2020-12-08 | $4.5M | — | Filing → |
| BHC | SELL | 2020-11-30 | $1.4M | — | Filing → |
| BHC | SELL | 2020-09-10 | $183K | — | Filing → |